Title: Recognizing the rise of cardiovascular disease as the world's leading cause of preventable death and disability and as a global public health crisis and supporting the recognition of February 2020 as "American Heart Month".
Policy area: Health

Summary:
This resolution expresses support for the recognition of American Heart Month to bring awareness to the cardiovascular disease public health crisis in the United States and abroad.



[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 860 Introduced in House (IH)]

<DOC>






116th CONGRESS
  2d Session
H. RES. 860

 Recognizing the rise of cardiovascular disease as the world's leading 
cause of preventable death and disability and as a global public health 
 crisis and supporting the recognition of February 2020 as ``American 
                             Heart Month''.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           February 14, 2020

  Mr. Smith of New Jersey (for himself and Mrs. Beatty) submitted the 
 following resolution; which was referred to the Committee on Foreign 
Affairs, and in addition to the Committee on Energy and Commerce, for a 
 period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                               RESOLUTION


 
 Recognizing the rise of cardiovascular disease as the world's leading 
cause of preventable death and disability and as a global public health 
 crisis and supporting the recognition of February 2020 as ``American 
                             Heart Month''.

Whereas the World Health Organization estimates that in 2017, 17.8 million 
        people died from cardiovascular diseases (referred to in this resolution 
        as ``CVDs'') globally;
Whereas of these deaths, 85 percent were due to heart attacks and strokes, and 
        over three-quarters of CVD deaths occur in low- and middle-income 
        countries;
Whereas CVDs result in tremendous health care costs and lost productivity and, 
        if not addressed, the United States alone will spend over $1,000,000,000 
        by 2035 on costs relating to CVD;
Whereas the heavy burden of death and disability from CVDs can be decreased 
        through changes in behavior linked to major risk factors, including 
        reduced tobacco use and salt consumption and improvements in access to 
        medical treatment and services;
Whereas essential quality-assured medicines and technologies are critical 
        components to address the global burden of CVDs; and
Whereas United States leadership and support has strengthened surveillance, 
        enhanced workforce capacity, and provided valuable technical exchanges 
        with respect to the prevention, diagnosis, and treatment of CVD: Now, 
        therefore, be it
    Resolved, That the House of Representatives--
            (1) supports the recognition of American Heart Month to 
        bring awareness to the cardiovascular disease (hereinafter 
        referred to as ``CVD'') public health crisis in the United 
        States and abroad;
            (2) affirms that the key to overcoming CVD is prevention 
        and early detection and treatment to reduce long-term 
        disability and mortality;
            (3) urges the deployment of United States technical 
        expertise on CVDs in support of developing capacities and 
        strengthening of the health care systems of other countries;
            (4) values the quality of life for CVD patients around the 
        world and their reintegration to society; and
            (5) calls on the Department of State, the United States 
        Agency for International Development, and the Centers for 
        Disease Control and Prevention, to--
                    (A) comprehensively examine the impact of CVDs on 
                health and development in United States priority 
                assistance countries; and
                    (B) develop a coordinated strategy that improves 
                the effectiveness and impact of United States-financed 
                global health programming by integrating CVD into 
                existing programs.
                                 <all>